Enhertu and Diarrhea: What Users Say
Reviews for Enhertu
- Anonymous
- Taken for less than 1 month
- April 27, 2023
For Stomach Cancer "As a patient, I can't rate the efficacy of this medication because I have had only one round. After many rounds of chemotherapy using other medications, I can say that the side effects of this medication were much worse and enduring after one round. Severe diarrhea, debilitating fatigue, debilitating nausea, and stomach pain. Side effects began on day four and lasted until day 7. Will take half dose next round but will continue on the regimen as prescribed for now. One lousy week out of three is not acceptable to me. If the next round is as bad, I will cease using this medication. The oncologist stated that while I tolerated other regimens better than most, I tolerated Enhertu worse than most."
- Ano...
- Taken for 1 to 6 months
- April 3, 2025
For Breast Cancer, Metastatic "Had done #6 cycle and dosage had reduced to 80% after the 2nd infusion due to liver dysfunction. The side effects are bowel system haywire, nausea, constipation, diarrhea, skin rashes, body heat, hair loss, and so on. The side effects are not getting better after each cycle. So helpless!!!!"
Frequently asked questions
- What is the success rate of Enhertu in metastatic breast cancer?
- Is Enhertu a chemotherapy drug? What's Enhertu used for?
- Ano...
- Taken for 1 to 6 months
- April 3, 2025
For Breast Cancer, Metastatic "Had done #6 cycle and dosage had reduced to 80% after the 2nd infusion due to liver dysfunction. The side effects are bowel system haywire, nausea, constipation, diarrhea, skin rashes, body heat, hair loss, and so on. The side effects are not getting better after each cycle. So helpless!!!!"
Are you taking this medicine?
Your review helps others make informed decisions.More about Enhertu (fam-trastuzumab deruxtecan)
- Enhertu consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (29)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: HER2 inhibitors
- En español
For Breast Cancer, Metastatic "Had 2 treatments with Enhertu. The side effects were bad and did not go away for a long time: dizziness, jitteriness in the entire body, fatigue, weakness, diarrhea, sick stomach, felt unwell all over and inside the body. Never, never would have another treatment with Enhertu!!"